Opexa Therapeutics (OPXA)

Add to Watchlists
Create an Alert
0.4411 -0.01  -1.98% NASDAQ Jul 2, 8:00PM Delayed 2m USD
View Full Chart
OPXA Price Chart
View All Events

OPXA Events

Date Type Description
05/12/2015 16:30 EDT Misc Opexa Therapeutics Inc First Quarter Earnings Conference Call in 2015
05/12/2015 Earnings Opexa Therapeutics Inc First Quarter Earnings in 2015 Release
02/23/2015 Earnings Opexa Therapeutics Inc Fourth Quarter Earnings Results in 2014
11/06/2014 17:00 EST Misc Q3 2014 Opexa Therapeutics Earnings Conference Call
11/06/2014 Earnings Q3 2014 Opexa Therapeutics Earnings Results
10/09/2014 Misc Opexa Therapeutics Announces Analyst and Investor Event
08/14/2014 17:00 EDT Misc Opexa Therapeutics Inc Q2 2014 Earnings Conference Call
08/14/2014 Earnings Opexa Therapeutics Inc Q2 2014 Earnings Results
View All Performance Charts

OPXA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Opexa Therapeutics is down 73.74% over the last year vs S&P 500 Total Return up 7.35%, Mast Therapeutics down 27.27%, and Biogen up 22.14%.

Advertisement

OPXA Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.opexatherapeutics.com
  • IR Website: http://www.opexatherapeutics.com/investors-relations/why-invest/default.aspx
  • HQ Country: United States
  • HQ State/Province: Texas
  • Incorporation Country: United States
  • Incorporation State/Province: Texas
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: March 31, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Opexa Therapeutics Inc is engaged in developing personalized immunotherapy to treat illnesses, including multiple sclerosis as well as other autoimmune diseases such as neuromyelitis optica. These therapies are based on proprietary T-cell technology.

OPXA Excel Add-In Codes

  • Name: =YCI("OPXA","name")
  • Description: =YCI("OPXA","description")
  • Sector: =YCI("OPXA","sector")
  • Industry: =YCI("OPXA","industry")
  • Est. Current Fiscal Year End: =YCI("OPXA","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.